Form 4 for CVS CVS Health
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0001127602-25-008726 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-07 | 2025-03-05 | CVS | Clark James David | SVP, Cont, Chief Acct Off | S - Sale+OE | $66.35 | -7,513 | 8,394 | -47% | -$498.5K |
| D | 2025-03-07 | 2025-03-05 | CVS | Clark James David | SVP, Cont, Chief Acct Off | M - OptEx | $62.21 | +7,513 | 15.9K | +90% | +$467.4K |
| D | 2025-03-07 | 2025-03-05 | CVS | Clark James David | SVP, Cont, Chief Acct Off | M - OptEx | $0.00 | -7,513 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | S | D | 7,513 | $66.35 | 8,394 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-05 | M | A | 7,513 | $62.21 | 15,907 | D | — | — | |
| 3 | Derivative | Stock Option | 2025-03-05 | M | D | 7,513 | $0.00 | 0 | D | $62.21 · 2019-04-01 to 2025-04-01 | 7,513 Common Stock | (F1) Options became exercisable in four equal annual installments, commencing 4/1/2019. |